Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.76
+0.19 (0.47%)
May 4, 2026, 1:00 PM EDT - Market open
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $6.15 billion as of May 4, 2026. Its market cap has increased by 290.25% in one year.
Market Cap
6.15B
Enterprise Value
5.96B
1-Year Change
290.25%
Ranking
Category
Stock Price
$39.76
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $6.15B, an increase of 251.65%. That is a compound annual growth rate of 29.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 6.12B | 67.52% |
| Dec 31, 2025 | 3.65B | 65.43% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
| May 28, 2021 | 1.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.64B |
| Protagonist Therapeutics | 6.28B |
| Cogent Biosciences | 6.26B |
| Terns Pharmaceuticals | 6.11B |
| Belite Bio | 6.09B |
| Celcuity | 6.07B |
| Apogee Therapeutics | 6.03B |
| Spyre Therapeutics | 5.99B |